What is Valneva SE ADR (VALN) stock price today?

Valneva SE ADR (VALN) currently trades at $5.38 per share. The stock has a market capitalization of $480.43M and a P/E ratio of —x.

Is VALN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Valneva SE ADR has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Valneva SE ADR's revenue and earnings?

Valneva SE ADR has trailing twelve-month (TTM) revenue of $174.66M with profit margins of -65.90%. Earnings per share (EPS) is $-1.59.

Is VALN stock overvalued or undervalued?

Based on our DCF model, Valneva SE ADR's intrinsic value is $10.28, representing a margin of safety of 2.53%. The stock currently trades at a P/E of —x.

VALN

Valneva SE ADR

NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY

$5.38

+0.94% today

Updated 2026-04-30

Market cap

$480.43M

P/E ratio

—

P/S ratio

2.75x

EPS (TTM)

$-1.59

Dividend yield

—

52W range

$5 – $12

Volume

0.1M

Market cap

$480.43M

P/E ratio

—

P/S ratio

2.75x

EPS (TTM)

$-1.59

Dividend yield

—

52W range

$5 – $12

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

5.3

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$12.22

+127.14%

12-Month target

—

Intrinsic (DCF)

$10.28

Margin of safety

+2.53%

0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -65.90%

- Negative free cash flow $-25.59M

- Revenue declining -9.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$361.30M	$153.71M	$169.58M	$174.66M	$174.66M
Net income	$-143.28M	$-101.43M	$-12.25M	$-115.19M	$-50.02M
EPS	—	—	—	—	$-1.59
Free cash flow	$-274.67M	$-217.06M	$-83.66M	$-57.38M	$-25.59M
Profit margin	-39.66%	-65.99%	-7.22%	-65.95%	-65.90%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VALN	$480.43M	20	2.7	2.0	5.3	5.0	+2.53%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Valneva SE ADR trades at $5.38. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $174.66M. with profit margins at -65.90%. Our DCF model estimates intrinsic value at $10.28.

Frequently asked questions

What is Valneva SE ADR's stock price?

Valneva SE ADR (VALN) trades at $5.38.

Is Valneva SE ADR overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $10.28.

What is the price target of Valneva SE ADR (VALN)?

The analyst target price is $12.22, representing +127.1% upside from the current price of $5.38.

What is the intrinsic value of Valneva SE ADR (VALN)?

Based on our DCF model, intrinsic value is $10.28, a +2.5% margin of safety versus $5.38.

What is Valneva SE ADR's revenue?

TTM revenue is $174.66M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.75x

ROE-80.20%

Beta1.53

50D MA$8.36

200D MA$9.01

Shares out0.09B

Float0.14B

Short ratio—

Avg volume0.1M

Performance

1 week+5.33%

1 month-10.66%

3 months-41.30%

YTD-37.30%

1 year—

3 years—

5 years—

Compare

VALN vs LLY →VALN vs JNJ →VALN vs ABBV →Stock screener →